Antibacterial effect of antibiotic solution on cellular viability in canine veins.
Pretreatment of tissue by using antibiotics is a critical step to prevent microbial contamination before venous transplantation. In this study, the optimal time and temperature of antibiotic solution treatment for maintaining cellular viability with antibacterial effect were investigated. The antibiotic-nutrient solutions were composed of cefoxitin, lincomycin, vancomycin, and polymyxin B in RPMI-1640 medium. After various antibiotic solution treatment times (4, 8, and 12 h) and temperatures (4, 25, and 37 degrees C), the viabilities of cells dissociated from veins (jugular vein, femoral vein, superior vena cava, and inferior vena cava) were determined. Double staining by Griffonia simplicifolia agglutins-fluorescein isothiocyanate (GS1-FITC) and propidium iodide was used. To measure the antibacterial effect of the antibiotic solution, canine veins were artificially infected by 3 kinds of bacteria (Staphylococcus aureus, Escherichia coli, and Klebsiella pneumoniae) and were treated by antibiotic solutions as viability test conditions. After the treatment with the antibiotic solution, the tissue was minced, and the homogenized tissue fraction was cultured on standard method agar. The colony that seemed to be resistant to the antibiotic solution was counted. At 37 and 25 degrees C, the viability of whole cells decreased significantly Asymptotic Significance 2-tailed (Asymp.Sig 2-tailed) < 0.05 after 4 h of antibiotic solution treatment, whereas at 4 degrees C it began to reduce significantly after 8 h of treatment. By antibiotic solution treatment at all 3 temperatures for 4 h, no significant difference in viability of the endothelial cells and whole cells was observed. To maintain the donor vein's cellular viability until transplantation, antibiotic solution treatment for 4 h at 4 degrees C is assumed to be appropriate.
Park
J C
JC
Department of Medical Engineering, Yonsei University College of Medicine, 134, Shinchon-dong, Seodaemun-ku, Seoul 120-752, Korea. hwal@yumc.yonsei.ac.kr
Sung
H J
HJ
Lee
D H
DH
Park
Y H
YH
Cho
B K
BK
Suh
H
H
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001424:Bacterial Infections / Q000517:prevention & control*; D002440:Cefoxitin / Q000494:pharmacology; D004285:Dogs; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects; D008034:Lincomycin / Q000494:pharmacology; D011112:Polymyxin B / Q000494:pharmacology; D012996:Solutions; D018709:Statistics, Nonparametric; D014640:Vancomycin / Q000494:pharmacology; D014680:Veins / Q000187:drug effects* / Q000637:transplantation
D000900:Anti-Bacterial Agents; D012996:Solutions; D002440:Cefoxitin; D014640:Vancomycin; D008034:Lincomycin; D011112:Polymyxin B